Meeting
2016 Gastrointestinal Cancers Symposium
Time to first-line chemotherapy and travel distance to the cancer center and their relationship to subsequent-line therapies in stage IV CRC.
Authors
Mahjabeen Fatima Iqbal
King's College London, London, United Kingdom
Mahjabeen Fatima Iqbal , Aleksi Emil Suo , Neha Papneja , Nayyer Iqbal , Tahir Abbas , Kamal Haider , Adnan Zaidi , Shahid Ahmed
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 724)
DOI
10.1200/jco.2016.34.4_suppl.724
Abstract #
724
Poster Bd #
L21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Adrenocortical carcinoma: Report of data from 66 patients with a rare disease at a cancer center.
First Author: Rafael Haikal dos Santos Abduch
Poster
2021 Gastrointestinal Cancers Symposium
Inoperable stage IV colorectal cancer with intact primary tumor in patients receiving palliative chemotherapy: Does the response to chemotherapy correlate between primary and metastatic sites? An Irish cancer center experience.
First Author: Ruba Hamed
Poster
2019 ASCO Annual Meeting
Chemotherapy rechallenge or reintroduction (CTr/r), regofenib (REG) and TAS-102 for metastatic pretreated colorectal cancer (mCRC) patients (pts): A propensity score analysis of treatment beyond second-line (PROSERpINA Study).
First Author: Maria Alessandra Calegari
Poster
2013 Gastrointestinal Cancers Symposium
Racial disparities and the outcome of metastatic (met) colorectal cancer (CRC).
First Author: Afsaneh Barzi